CN Stock MarketDetailed Quotes

300601 Shenzhen Kangtai Biological Products

Watchlist
  • 14.42
  • -0.18-1.23%
Market Closed Aug 30 15:00 CST
16.11BMarket Cap31.21P/E (TTM)

Shenzhen Kangtai Biological Products Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-58.33%323.14M
-8.06%876.16M
17.49%1.2B
-16.26%1.03B
-70.52%775.52M
-68.55%953.01M
-71.33%1.02B
-68.63%1.23B
38.12%2.63B
150.10%3.03B
Transactional financial assets
--0
565.32%120.8M
-77.31%100.02M
-93.71%18.12M
-40.59%18.02M
-39.67%18.16M
--440.83M
42.71%288.02M
-95.23%30.34M
-97.99%30.09M
Notes receivable and accounts receivable
1.78%2.8B
9.49%2.72B
21.55%2.79B
12.70%2.65B
24.21%2.75B
25.79%2.48B
23.43%2.29B
35.20%2.35B
22.04%2.22B
24.18%1.97B
-Notes receivable
----
----
----
----
----
----
----
--0
--0
----
-Accounts receivable
1.78%2.8B
9.49%2.72B
21.55%2.79B
12.70%2.65B
24.21%2.75B
25.79%2.48B
57.02%2.29B
35.20%2.35B
22.04%2.22B
24.18%1.97B
Other receivables (including interest and dividends)
-19.04%8.47M
-18.66%9.55M
-21.77%8.9M
-90.62%11.04M
-61.78%10.46M
-97.25%11.75M
-20.14%11.38M
409.85%117.65M
-66.15%27.36M
884.71%426.51M
-Other receivable
-19.04%8.47M
----
-21.77%8.9M
----
-61.78%10.46M
----
-20.14%11.38M
----
-66.15%27.36M
----
Advance payment
-44.60%30.79M
-53.11%34.69M
-59.35%44.73M
-31.24%59.79M
-36.27%55.57M
-28.63%73.99M
-7.50%110.04M
-28.64%86.96M
-37.12%87.21M
-3.27%103.67M
Inventories
10.47%894.84M
12.40%896M
6.19%772.85M
3.50%852.44M
-12.82%810.04M
-26.40%797.14M
-31.22%727.8M
-11.12%823.65M
12.58%929.13M
81.52%1.08B
Receivable financing
--0
----
--190.41K
--245.07K
----
----
--0
----
----
2,122.22%400K
Other current assets
-54.43%459.11M
-56.45%341.62M
-15.29%486.12M
-20.05%802.58M
44.92%1.01B
14.11%784.48M
-22.63%573.88M
5,537.67%1B
6,496.96%695.23M
457.28%687.47M
Total current assets
-16.79%4.52B
-2.43%4.99B
4.27%5.4B
-8.08%5.43B
-17.92%5.43B
-30.19%5.12B
-29.50%5.17B
-15.15%5.91B
22.25%6.62B
41.93%7.33B
Non Current assets
Investment real estate
1,005,687.28%494.92M
854,148.17%420.35M
861,108.80%423.77M
0.00%49.21K
0.00%49.21K
0.00%49.21K
0.00%49.21K
0.00%49.21K
0.00%49.21K
0.00%49.21K
Fixed assets
----
----
----
----
19.08%2.07B
----
-4.63%1.71B
----
1.32%1.74B
----
Constru in process
-57.17%1.48B
----
-34.12%2.28B
----
23.62%3.45B
----
49.26%3.46B
----
114.24%2.79B
----
Intangible assets
29.86%452.97M
20.68%426.15M
21.08%433.45M
29.58%434.92M
3.97%348.81M
3.73%353.13M
3.45%357.98M
-4.17%335.62M
15.26%335.5M
17.42%340.44M
Development expenditure
-66.02%51.88M
-42.49%76.24M
-39.60%70.78M
-75.82%66.04M
-40.36%152.68M
-74.21%132.58M
-69.97%117.18M
124.14%273.05M
194.04%256.01M
501.91%514.13M
Long deferred expense
12.43%84.18M
27.87%92.3M
29.10%101.68M
43.16%117.98M
-15.23%74.87M
-22.49%72.18M
-20.74%78.76M
-21.08%82.41M
-20.58%88.33M
-21.29%93.12M
Deferred tax assets
0.57%657.14M
-7.25%623.5M
-11.01%630.32M
18.02%630.32M
18.55%653.45M
28.30%672.22M
26.80%708.32M
-12.89%534.07M
-17.24%551.19M
-25.37%523.94M
Other non current assets
19.92%2.52B
22.90%2.66B
6.46%2.31B
12.96%2.23B
52.05%2.1B
59.96%2.16B
67.47%2.17B
16.95%1.97B
2.82%1.38B
19.53%1.35B
Total non current assets
12.11%9.93B
15.43%10.03B
12.52%9.69B
16.85%9.29B
23.92%8.85B
21.88%8.69B
26.49%8.61B
25.59%7.95B
29.44%7.14B
48.31%7.13B
Total assets
1.12%14.45B
8.81%15.02B
9.42%15.09B
6.23%14.72B
3.80%14.29B
-4.53%13.8B
-2.56%13.79B
4.26%13.86B
25.88%13.76B
45.01%14.46B
Liabilities
Current liabilities
Short term loan
-4.68%158.6M
23.70%206.96M
-64.70%60.04M
-35.89%166.45M
-56.86%166.39M
-63.98%167.31M
-78.13%170.07M
-47.17%259.65M
11.48%385.65M
221.78%464.51M
Notes payable and accounts payable
66.16%794.78M
74.89%779.48M
103.27%882.48M
142.09%752.59M
84.81%478.31M
66.01%445.69M
-38.70%434.13M
11.10%310.88M
-2.90%258.82M
70.71%268.47M
-Notes payable
-18.23%98.35M
-38.06%95.24M
-20.23%91.3M
15.68%111.11M
160.38%120.27M
--153.78M
--114.46M
--96.05M
1,291.30%46.19M
----
-Accounts payable
94.51%696.43M
134.39%684.24M
147.50%791.18M
198.60%641.48M
68.39%358.04M
8.73%291.92M
-54.86%319.67M
-23.23%214.83M
-19.23%212.63M
82.96%268.47M
Contract liabilities
-9.33%18.12M
-24.32%22.59M
-9.22%28.35M
-35.59%25.8M
-46.27%19.98M
-61.35%29.85M
-66.96%31.23M
-54.43%40.05M
-62.77%37.19M
243.13%77.23M
Advance receipts
--2.99M
--255K
--409.25K
--195.96K
----
----
--0
----
----
----
Salaries payable
10.79%32.84M
120.00%63.51M
4.42%75.35M
-7.94%28.28M
-8.75%29.64M
-40.29%28.87M
10.46%72.16M
39.17%30.72M
56.93%32.48M
113.38%48.35M
Taxs payable
-10.80%18.95M
-27.76%16.87M
-85.08%25.86M
-90.56%16.84M
-88.83%21.24M
-89.44%23.36M
76.64%173.37M
-24.70%178.46M
-73.93%190.17M
-68.97%221.14M
Other payable (including interest and dividends)
-0.79%1.54B
7.90%1.51B
21.51%1.65B
16.09%1.52B
28.33%1.55B
43.62%1.4B
59.52%1.35B
48.13%1.31B
36.22%1.21B
21.98%976.11M
-Other payable
-0.79%1.54B
----
21.51%1.65B
----
28.33%1.55B
----
59.52%1.35B
----
36.22%1.21B
----
Non current liabilities due within one year
12.53%128.56M
34.92%142.47M
-68.81%32.32M
674.06%16.33M
503.08%114.24M
488.47%105.59M
358.42%103.61M
-89.80%2.11M
3.00%18.94M
2.24%17.94M
Other current liabilities
-15.33%507.55K
-24.32%677.63K
-5.85%881.98K
-35.43%775.82K
-46.27%599.45K
-60.64%895.41K
-66.82%936.8K
-54.23%1.2M
-62.62%1.12M
242.88%2.28M
Total current liabilities
13.14%2.69B
24.60%2.75B
17.59%2.75B
18.52%2.52B
11.64%2.38B
6.14%2.2B
-10.63%2.34B
5.24%2.13B
-10.06%2.13B
10.55%2.08B
Current liabilities
Long term loan
-81.01%85M
26.43%559.86M
65.86%671.26M
23.28%556.35M
3.84%447.63M
10.38%442.82M
-3.07%404.71M
24.29%451.29M
64.57%431.07M
81.14%401.19M
Bonds payable
5.32%1.75B
5.46%1.72B
5.59%1.7B
5.74%1.68B
5.86%1.66B
5.91%1.63B
5.95%1.61B
6.02%1.59B
--1.57B
--1.54B
Estimate liabilities
73.78%76.49M
126.51%54.03M
77.56%64.51M
--23.51M
--44.02M
93.82%23.85M
3.42%36.33M
--0
--0
--12.31M
Deferred tax liabilities
2.32%24.98M
3.10%26.85M
3.09%26.89M
-20.46%24.37M
-38.47%24.41M
-37.14%26.05M
-37.10%26.08M
-25.35%30.63M
116.56%39.67M
120.44%41.43M
Long term deferred income
-15.85%286.58M
-24.64%289.88M
-14.20%328.7M
-5.81%337.63M
-3.84%340.55M
8.13%384.67M
9.60%383.1M
3.31%358.46M
18.99%354.16M
28.83%355.75M
Other non current liabilities
----
----
----
----
--0
----
----
----
----
----
Total non current liabilities
-11.75%2.22B
5.67%2.65B
13.45%2.79B
7.93%2.62B
5.16%2.51B
6.71%2.51B
4.11%2.46B
7.98%2.43B
313.66%2.39B
355.74%2.35B
Total liabilities
0.35%4.91B
14.52%5.4B
15.47%5.54B
12.88%5.15B
8.21%4.89B
6.44%4.71B
-3.64%4.8B
6.68%4.56B
53.39%4.52B
84.99%4.43B
Shareholders equity
Paid-in capital
0.00%1.12B
0.00%1.12B
-0.32%1.12B
-0.32%1.12B
-0.32%1.12B
59.49%1.12B
63.08%1.12B
63.09%1.12B
63.11%1.12B
2.02%700.3M
Other equity instruments
-0.01%511.1M
-0.01%511.1M
-0.01%511.1M
-0.00%511.14M
-0.02%511.14M
-0.02%511.14M
-0.03%511.14M
-0.03%511.16M
--511.22M
--511.24M
Capital reserve funds
0.96%5.42B
0.42%5.4B
-2.19%5.37B
-1.86%5.37B
-1.86%5.37B
-9.45%5.37B
2.48%5.49B
0.58%5.47B
0.79%5.47B
10.84%5.93B
Surplus reserve funds
34.85%327.56M
34.85%327.56M
34.85%327.56M
37.27%242.9M
37.27%242.9M
37.27%242.9M
37.27%242.9M
12.89%176.95M
12.89%176.95M
12.89%176.95M
Retained profit
0.33%2.16B
22.97%2.27B
35.07%2.22B
14.45%2.34B
9.76%2.15B
-31.83%1.85B
-32.60%1.64B
-8.31%2.04B
13.02%1.96B
90.33%2.71B
Less:Treasury stock
----
----
----
----
--0
----
3,514.82%20M
3,514.82%20M
--0
----
Other composite income
---54.41K
----
--0
----
----
----
----
----
----
----
Shareholders equity without minority interests
1.52%9.53B
5.85%9.62B
6.19%9.54B
2.96%9.58B
1.64%9.39B
-9.37%9.09B
-1.98%8.99B
3.11%9.3B
15.73%9.24B
32.37%10.03B
Minority interests
--15.67K
---36.97K
--0
----
----
----
----
----
----
----
Total shareholder equity
1.52%9.53B
5.85%9.62B
6.19%9.54B
2.96%9.58B
1.64%9.39B
-9.37%9.09B
-1.98%8.99B
3.11%9.3B
15.73%9.24B
32.37%10.03B
Total liabilityies and equity
1.12%14.45B
8.81%15.02B
9.42%15.09B
6.23%14.72B
3.80%14.29B
-4.53%13.8B
-2.56%13.79B
4.26%13.86B
25.88%13.76B
45.01%14.46B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -58.33%323.14M-8.06%876.16M17.49%1.2B-16.26%1.03B-70.52%775.52M-68.55%953.01M-71.33%1.02B-68.63%1.23B38.12%2.63B150.10%3.03B
Transactional financial assets --0565.32%120.8M-77.31%100.02M-93.71%18.12M-40.59%18.02M-39.67%18.16M--440.83M42.71%288.02M-95.23%30.34M-97.99%30.09M
Notes receivable and accounts receivable 1.78%2.8B9.49%2.72B21.55%2.79B12.70%2.65B24.21%2.75B25.79%2.48B23.43%2.29B35.20%2.35B22.04%2.22B24.18%1.97B
-Notes receivable ------------------------------0--0----
-Accounts receivable 1.78%2.8B9.49%2.72B21.55%2.79B12.70%2.65B24.21%2.75B25.79%2.48B57.02%2.29B35.20%2.35B22.04%2.22B24.18%1.97B
Other receivables (including interest and dividends) -19.04%8.47M-18.66%9.55M-21.77%8.9M-90.62%11.04M-61.78%10.46M-97.25%11.75M-20.14%11.38M409.85%117.65M-66.15%27.36M884.71%426.51M
-Other receivable -19.04%8.47M-----21.77%8.9M-----61.78%10.46M-----20.14%11.38M-----66.15%27.36M----
Advance payment -44.60%30.79M-53.11%34.69M-59.35%44.73M-31.24%59.79M-36.27%55.57M-28.63%73.99M-7.50%110.04M-28.64%86.96M-37.12%87.21M-3.27%103.67M
Inventories 10.47%894.84M12.40%896M6.19%772.85M3.50%852.44M-12.82%810.04M-26.40%797.14M-31.22%727.8M-11.12%823.65M12.58%929.13M81.52%1.08B
Receivable financing --0------190.41K--245.07K----------0--------2,122.22%400K
Other current assets -54.43%459.11M-56.45%341.62M-15.29%486.12M-20.05%802.58M44.92%1.01B14.11%784.48M-22.63%573.88M5,537.67%1B6,496.96%695.23M457.28%687.47M
Total current assets -16.79%4.52B-2.43%4.99B4.27%5.4B-8.08%5.43B-17.92%5.43B-30.19%5.12B-29.50%5.17B-15.15%5.91B22.25%6.62B41.93%7.33B
Non Current assets
Investment real estate 1,005,687.28%494.92M854,148.17%420.35M861,108.80%423.77M0.00%49.21K0.00%49.21K0.00%49.21K0.00%49.21K0.00%49.21K0.00%49.21K0.00%49.21K
Fixed assets ----------------19.08%2.07B-----4.63%1.71B----1.32%1.74B----
Constru in process -57.17%1.48B-----34.12%2.28B----23.62%3.45B----49.26%3.46B----114.24%2.79B----
Intangible assets 29.86%452.97M20.68%426.15M21.08%433.45M29.58%434.92M3.97%348.81M3.73%353.13M3.45%357.98M-4.17%335.62M15.26%335.5M17.42%340.44M
Development expenditure -66.02%51.88M-42.49%76.24M-39.60%70.78M-75.82%66.04M-40.36%152.68M-74.21%132.58M-69.97%117.18M124.14%273.05M194.04%256.01M501.91%514.13M
Long deferred expense 12.43%84.18M27.87%92.3M29.10%101.68M43.16%117.98M-15.23%74.87M-22.49%72.18M-20.74%78.76M-21.08%82.41M-20.58%88.33M-21.29%93.12M
Deferred tax assets 0.57%657.14M-7.25%623.5M-11.01%630.32M18.02%630.32M18.55%653.45M28.30%672.22M26.80%708.32M-12.89%534.07M-17.24%551.19M-25.37%523.94M
Other non current assets 19.92%2.52B22.90%2.66B6.46%2.31B12.96%2.23B52.05%2.1B59.96%2.16B67.47%2.17B16.95%1.97B2.82%1.38B19.53%1.35B
Total non current assets 12.11%9.93B15.43%10.03B12.52%9.69B16.85%9.29B23.92%8.85B21.88%8.69B26.49%8.61B25.59%7.95B29.44%7.14B48.31%7.13B
Total assets 1.12%14.45B8.81%15.02B9.42%15.09B6.23%14.72B3.80%14.29B-4.53%13.8B-2.56%13.79B4.26%13.86B25.88%13.76B45.01%14.46B
Liabilities
Current liabilities
Short term loan -4.68%158.6M23.70%206.96M-64.70%60.04M-35.89%166.45M-56.86%166.39M-63.98%167.31M-78.13%170.07M-47.17%259.65M11.48%385.65M221.78%464.51M
Notes payable and accounts payable 66.16%794.78M74.89%779.48M103.27%882.48M142.09%752.59M84.81%478.31M66.01%445.69M-38.70%434.13M11.10%310.88M-2.90%258.82M70.71%268.47M
-Notes payable -18.23%98.35M-38.06%95.24M-20.23%91.3M15.68%111.11M160.38%120.27M--153.78M--114.46M--96.05M1,291.30%46.19M----
-Accounts payable 94.51%696.43M134.39%684.24M147.50%791.18M198.60%641.48M68.39%358.04M8.73%291.92M-54.86%319.67M-23.23%214.83M-19.23%212.63M82.96%268.47M
Contract liabilities -9.33%18.12M-24.32%22.59M-9.22%28.35M-35.59%25.8M-46.27%19.98M-61.35%29.85M-66.96%31.23M-54.43%40.05M-62.77%37.19M243.13%77.23M
Advance receipts --2.99M--255K--409.25K--195.96K----------0------------
Salaries payable 10.79%32.84M120.00%63.51M4.42%75.35M-7.94%28.28M-8.75%29.64M-40.29%28.87M10.46%72.16M39.17%30.72M56.93%32.48M113.38%48.35M
Taxs payable -10.80%18.95M-27.76%16.87M-85.08%25.86M-90.56%16.84M-88.83%21.24M-89.44%23.36M76.64%173.37M-24.70%178.46M-73.93%190.17M-68.97%221.14M
Other payable (including interest and dividends) -0.79%1.54B7.90%1.51B21.51%1.65B16.09%1.52B28.33%1.55B43.62%1.4B59.52%1.35B48.13%1.31B36.22%1.21B21.98%976.11M
-Other payable -0.79%1.54B----21.51%1.65B----28.33%1.55B----59.52%1.35B----36.22%1.21B----
Non current liabilities due within one year 12.53%128.56M34.92%142.47M-68.81%32.32M674.06%16.33M503.08%114.24M488.47%105.59M358.42%103.61M-89.80%2.11M3.00%18.94M2.24%17.94M
Other current liabilities -15.33%507.55K-24.32%677.63K-5.85%881.98K-35.43%775.82K-46.27%599.45K-60.64%895.41K-66.82%936.8K-54.23%1.2M-62.62%1.12M242.88%2.28M
Total current liabilities 13.14%2.69B24.60%2.75B17.59%2.75B18.52%2.52B11.64%2.38B6.14%2.2B-10.63%2.34B5.24%2.13B-10.06%2.13B10.55%2.08B
Current liabilities
Long term loan -81.01%85M26.43%559.86M65.86%671.26M23.28%556.35M3.84%447.63M10.38%442.82M-3.07%404.71M24.29%451.29M64.57%431.07M81.14%401.19M
Bonds payable 5.32%1.75B5.46%1.72B5.59%1.7B5.74%1.68B5.86%1.66B5.91%1.63B5.95%1.61B6.02%1.59B--1.57B--1.54B
Estimate liabilities 73.78%76.49M126.51%54.03M77.56%64.51M--23.51M--44.02M93.82%23.85M3.42%36.33M--0--0--12.31M
Deferred tax liabilities 2.32%24.98M3.10%26.85M3.09%26.89M-20.46%24.37M-38.47%24.41M-37.14%26.05M-37.10%26.08M-25.35%30.63M116.56%39.67M120.44%41.43M
Long term deferred income -15.85%286.58M-24.64%289.88M-14.20%328.7M-5.81%337.63M-3.84%340.55M8.13%384.67M9.60%383.1M3.31%358.46M18.99%354.16M28.83%355.75M
Other non current liabilities ------------------0--------------------
Total non current liabilities -11.75%2.22B5.67%2.65B13.45%2.79B7.93%2.62B5.16%2.51B6.71%2.51B4.11%2.46B7.98%2.43B313.66%2.39B355.74%2.35B
Total liabilities 0.35%4.91B14.52%5.4B15.47%5.54B12.88%5.15B8.21%4.89B6.44%4.71B-3.64%4.8B6.68%4.56B53.39%4.52B84.99%4.43B
Shareholders equity
Paid-in capital 0.00%1.12B0.00%1.12B-0.32%1.12B-0.32%1.12B-0.32%1.12B59.49%1.12B63.08%1.12B63.09%1.12B63.11%1.12B2.02%700.3M
Other equity instruments -0.01%511.1M-0.01%511.1M-0.01%511.1M-0.00%511.14M-0.02%511.14M-0.02%511.14M-0.03%511.14M-0.03%511.16M--511.22M--511.24M
Capital reserve funds 0.96%5.42B0.42%5.4B-2.19%5.37B-1.86%5.37B-1.86%5.37B-9.45%5.37B2.48%5.49B0.58%5.47B0.79%5.47B10.84%5.93B
Surplus reserve funds 34.85%327.56M34.85%327.56M34.85%327.56M37.27%242.9M37.27%242.9M37.27%242.9M37.27%242.9M12.89%176.95M12.89%176.95M12.89%176.95M
Retained profit 0.33%2.16B22.97%2.27B35.07%2.22B14.45%2.34B9.76%2.15B-31.83%1.85B-32.60%1.64B-8.31%2.04B13.02%1.96B90.33%2.71B
Less:Treasury stock ------------------0----3,514.82%20M3,514.82%20M--0----
Other composite income ---54.41K------0----------------------------
Shareholders equity without minority interests 1.52%9.53B5.85%9.62B6.19%9.54B2.96%9.58B1.64%9.39B-9.37%9.09B-1.98%8.99B3.11%9.3B15.73%9.24B32.37%10.03B
Minority interests --15.67K---36.97K--0----------------------------
Total shareholder equity 1.52%9.53B5.85%9.62B6.19%9.54B2.96%9.58B1.64%9.39B-9.37%9.09B-1.98%8.99B3.11%9.3B15.73%9.24B32.37%10.03B
Total liabilityies and equity 1.12%14.45B8.81%15.02B9.42%15.09B6.23%14.72B3.80%14.29B-4.53%13.8B-2.56%13.79B4.26%13.86B25.88%13.76B45.01%14.46B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg